Jens Rovelt

Jens Rovelt is a Guest Researcher in the Department of Drug Design and Pharmacology at the University of Copenhagen, concurrently serving as Senior Development Scientist at Astellas Pharma Inc. His academic background includes an MSc in Bioinformatics and a PhD.

His primary research focuses on risk factors for glaucoma and ocular health, extending to dry eye disease, ocular surface disorders, and retinal vessel morphology. He employs large-scale epidemiological approaches, notably through the FOREVER cohort involving over 57,000 subjects, to investigate systemic-ocular disease relationships including associations with atopic dermatitis and diabetes.

Rovelt's recent publications (2024-2025) demonstrate a consistent emphasis on population-based ophthalmic research, with key themes including glaucoma risk stratification, dry eye symptomatology linked to artificial tear formulations, and vascular/metabolic factors influencing eye health. His work frequently involves multi-institutional collaborations and leverages datasets exceeding 60,000 participants for robust statistical analysis.